Related references
Note: Only part of the references are listed.Neuronal and astrocytic CB1R signaling differentially modulates goal-directed behavior and working memory by distinct temporal mechanisms
Huiping Shang et al.
NEUROPSYCHOPHARMACOLOGY (2023)
The expression analyses of GSK3B, VEGF, ANG1, and ANG2 in human brain microvascular endothelial cells treated with the synthetic cannabinoid XLR-11
Laith AL-Eitan et al.
GENE (2023)
Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke A Randomized Clinical Trial
Anxin Wang et al.
JAMA NEUROLOGY (2023)
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Jiangling Peng et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2022)
Endocannabinoids and cortical plasticity: CB1R as a possible regulator of the excitation/inhibition balance in health and disease
Lucas J. A. Durieux et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2022)
Inhibition of Prostaglandin E2 Receptor EP3 Attenuates Oxidative Stress and Neuronal Apoptosis Partially by Modulating p38MAPK/FOXO3/Mul1/Mfn2 Pathway after Subarachnoid Hemorrhage in Rats
Yu Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)
Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke
Zihuan Shen et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Cell type specific cannabinoid CB1 receptor distribution across the human and non-human primate cortex
Shinnyi Chou et al.
SCIENTIFIC REPORTS (2022)
Cannabinoid Type 1 Receptors in the Basolateral Amygdala Regulate ACPA-Induced Place Preference and Anxiolytic-Like Behaviors
Tomohiro Tokutake et al.
NEUROCHEMICAL RESEARCH (2022)
Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer's disease
Vasil Kecheliev et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM
Spandana Maddukuri et al.
ARTHRITIS RESEARCH & THERAPY (2022)
The Cannabinoid Receptor Agonist, WIN, Suppresses the Activation of Proinflammatory Genes Induced by Interleukin 1 Beta in Human Astrocytes
Jerel Adam Fields et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
CB2 Receptor in Microglia: The Guardian of Self-Control
Joanna Agnieszka Komorowska-Mueller et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement
Dimitris Spyridakos et al.
NEUROCHEMISTRY INTERNATIONAL (2021)
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke A Phase III, Randomized, Double-Blind, Comparative Trial
Jie Xu et al.
STROKE (2021)
Endocannabinoids in immune regulation and immunopathologies
Oindrila Rahaman et al.
IMMUNOLOGY (2021)
Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation
Ludmila A. Kasatkina et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Biased Coupling to β-Arrestin of Two Common Variants of the CB2 Cannabinoid Receptor
Gabor Turu et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Control of glutamate release by complexes of adenosine and cannabinoid receptors
Attila Kofalvi et al.
BMC BIOLOGY (2020)
Ischemia-Triggered Glutamate Excitotoxicity From the Perspective of Glial Cells
Denisa Belov Kirdajova et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back
Osnat Almogi-Hazan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cannabinoid CB1 receptor agonist ACEA alleviates brain ischemia/reperfusion injury via CB1-Drp1 pathway
Shuai Yang et al.
CELL DEATH DISCOVERY (2020)
Long-term depression induced by endogenous cannabinoids produces neuroprotection via astroglial CB1R after stroke in rodents
Feng Wang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)
GPCR Signaling Regulation: The Role of GRKs and Arrestins
Vsevolod V. Gurevich et al.
FRONTIERS IN PHARMACOLOGY (2019)
Endocannabinoid Signaling Mediates Local Dendritic Coordination between Excitatory and Inhibitory Synapses
Hai Yin Hu et al.
CELL REPORTS (2019)
The Acute Activation of the CB1 Receptor in the Hippocampus Decreases Neurotoxicity and Prevents Spatial Memory Impairment in Rats Lesioned with β-Amyloid 25-35
Aleidy Patricio-Martinez et al.
NEUROSCIENCE (2019)
Neuroimmune crosstalk in central nervous system injury-induced infection and pharmacological intervention
Ying-ying Huang et al.
BRAIN RESEARCH BULLETIN (2019)
The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia
M. Mecha et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
The endocannabinoid system and stroke: A focused review
Bradley Kolb et al.
BRAIN CIRCULATION (2019)
Monoacylglycerol lipase inhibitor, JZL-184, confers neuroprotection in the mice middle cerebral artery occlusion model of stroke
Mohammad-Reza Rahmani et al.
LIFE SCIENCES (2018)
Emerging strategies targeting CB2 cannabinoid receptor: Biased agonism and allosterism
Paula Morales et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke
Isabel Bravo-Ferrer et al.
STROKE (2017)
Microglial repopulation resolves inflammation and promotes brain recovery after injury
Rachel A. Rice et al.
GLIA (2017)
Brain Ischemia Suppresses Immunity in the Periphery and Brain via Different Neurogenic Innervations
Qiang Liu et al.
IMMUNITY (2017)
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways
Shao-Hua Su et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2017)
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
Marjolein Soethoudt et al.
NATURE COMMUNICATIONS (2017)
A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by Modulating the Endocannabinoid System in HT22 Cells
Xin Li et al.
Frontiers in Neuroscience (2017)
Neuroprotective Role of the PI3 Kinase/Akt Signalling Pathway in Zebrafish
Shuang Chen et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Gamma-Secretase Inhibitors Attenuate Neurotrauma and Neurogenic Acute Lung Injury in Rats by Rescuing the Accumulation of Hypertrophic Microglia
Hung-Jung Lin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Acute brain trauma, lung injury, and pneumonia: more than just altered mental status and decreased airway protection
Parker J. Hu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental GMH rat model
Yihao Tao et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
The CB2 receptor and its role as a regulator of inflammation
Caroline Turcotte et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain
Herbert H. Seltzman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Long-Term Survival Following Traumatic Brain Injury: A Population-Based Parametric Survival Analysis
Gordon W. Fuller et al.
NEUROEPIDEMIOLOGY (2016)
The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia
Zachary Wilmer Reichenbach et al.
NEUROSCIENCE LETTERS (2016)
Endocannabinoid CB1 receptor activation upon global ischemia adversely impact recovery of reward and stress signaling molecules, neuronal survival and behavioral impulsivity
Megan Dunbar Knowles et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Orchestrated activation of mGluR5 and CB1 promotes neuroprotection
Edleusa M. L. Batista et al.
MOLECULAR BRAIN (2016)
A Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its Derivatives
Idriss Ali Abdoulaye et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Endocannabinoids drive the acquisition of an alternative phenotype in microglia
M. Mecha et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs
Marta Andres-Mach et al.
BRAIN RESEARCH (2015)
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
C. Blazquez et al.
CELL DEATH AND DIFFERENTIATION (2015)
Hypoxia induces microglia autophagy and neural inflammation injury in focal cerebral ischemia model
Zhao Yang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
Risk factors for ventilator-associated pneumonia in patients with severe traumatic brain injury in a Serbian trauma centre
Bojan Jovanovic et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons inischemic stroke in mice
Laura Caltana et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium
Yuri Persidsky et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures
Natalia Malek et al.
NEURAL PLASTICITY (2015)
Time-Dependent Protection of CB2 Receptor Agonist in Stroke
Seong-Jin Yu et al.
PLOS ONE (2015)
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS
Weimin Kong et al.
CELLULAR IMMUNOLOGY (2014)
Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1 Receptor-Mediated Type 2 NADPH Oxidase
Ji Jia et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Hai-Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Excitotoxicity and stroke: Identifying novel targets for neuroprotection
Ted Weita Lai et al.
PROGRESS IN NEUROBIOLOGY (2014)
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation
L. Latini et al.
CELL DEATH & DISEASE (2014)
WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats
Jing Sun et al.
ACTA PHARMACOLOGICA SINICA (2013)
The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action
D. M. Kerr et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Differential Expression of Intracellular and Extracellular CB2 Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes
Julie T. Castaneda et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Conformational biosensors reveal GPCR signalling from endosomes
Roshanak Irannejad et al.
NATURE (2013)
Endogenous cannabinoids revisited: A biochemistry perspective
B. M. Fonseca et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABAA receptors
R. Baur et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The Role of Cannabinoids in Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
Alessandro Pini et al.
CURRENT DRUG TARGETS (2012)
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells
Fernando Correa et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2011)
Pathophysiology, treatment, and animal and cellular models of human ischemic stroke
Trent M. Woodruff et al.
MOLECULAR NEURODEGENERATION (2011)
Cannabinoid receptor 1 induces a biphasic ERK activation via multiprotein signaling complex formation of proximal kinases PKCε, Src, and Fyn in primary neurons
Olga Asimaki et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
GABAergic and Cortical and Subcortical Glutamatergic Axon Terminals Contain CB1 Cannabinoid Receptors in the Ventromedial Nucleus of the Hypothalamus
Leire Reguero et al.
PLOS ONE (2011)
The cannabinoid receptor agonist WIN 55,212-2 reduces the initial cerebral damage after hypoxic-ischemic injury in fetal lambs
Daniel Alonso-Alconada et al.
BRAIN RESEARCH (2010)
CB2: a cannabinoid receptor with an identity crisis
Brady K. Atwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Anandamide Enhances IL-10 Production in Activated Microglia by Targeting CB2 Receptors: Roles of ERK1/2, JNK, and NF-κB
Fernando Correa et al.
GLIA (2010)
Δ9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus
Nora Laaris et al.
NEUROPHARMACOLOGY (2010)
Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors
Maria Teresa Cencioni et al.
PLOS ONE (2010)
A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells
Fernando Correa et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
Guy A. Cabral et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Cannabinoid Receptor Type 1-and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling
Christine Boerner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway
Maria Teresa Viscomi et al.
JOURNAL OF NEUROSCIENCE (2009)
CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury
Ming Zhang et al.
MICROVASCULAR RESEARCH (2009)
Temporal and Spatial Dynamics of Cerebral Immune Cell Accumulation in Stroke
Mathias Gelderblom et al.
STROKE (2009)
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond
Roger G. Pertwee
ADDICTION BIOLOGY (2008)
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways
Fabrizio Montecucco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Ultrastructural Localization of Neuronal Brain CB2 Cannabinoid Receptors
A. Brusco et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
Cannabinoid CB2 receptors in human brain inflammation
C. Benito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective Agonists
John C. Ashton et al.
CURRENT MEDICINAL CHEMISTRY (2008)
The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat
Li Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model
Ming Zhang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils
R Kurihara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
D Panikashvili et al.
NEUROBIOLOGY OF DISEASE (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells
E Eljaschewitsch et al.
NEURON (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition
D Panikashvili et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
J Joseph et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor
A Klegeris et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
D Panikashvili et al.
NATURE (2001)
Share Paper
